Search

Your search keyword '"GADA, HEMAL"' showing total 400 results

Search Constraints

Start Over You searched for: Author "GADA, HEMAL" Remove constraint Author: "GADA, HEMAL"
400 results on '"GADA, HEMAL"'

Search Results

3. Abstract 4144096: Outcomes of Left Atrial Appendage Occlusion in Patients with Atrial Fibrillation and Gastrointestinal Bleeding: Insights from a Multicenter Registry

4. Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis Patients

5. Use and performance of the evolut FX transcatheter aortic valve system

11. 1-Year Outcomes From the CLASP IID Randomized Trial for Degenerative Mitral Regurgitation

12. 1-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results

14. Transcatheter Left Ventricular Restoration in Patients With Heart Failure

15. Clinical Impact of Standardized TAVR Technique and Care Pathway: Insights From the Optimize PRO Study

17. Randomized Comparison of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in Prohibitive Surgical Risk Patients

18. Aortic Annulus S-Curve: Implications for Transcatheter Aortic Valve Replacement and Related Procedures, Part 1

19. Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study

20. Combined left atrial appendage occlusion and catheter ablation procedure for left atrial arrhythmias: A real‐world, propensity‐matched analysis.

21. Transcatheter Aortic Valve Implantation by Valve Type in Women With Small Annuli: Results From the SMART Randomized Clinical Trial.

23. Balloon-Expandable Valve for Treatment of Evolut Valve Failure: Implications on Neoskirt Height and Leaflet Overhang

24. 30-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results

29. Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.

31. Propensity-Matched Comparison of Evolut-R Transcatheter Aortic Valve Implantation With Surgery in Intermediate-Risk Patients (from the SURTAVI Trial)

32. Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial

34. 3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study.

38. Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients.

41. TAVR in Intermediate-Risk Patients: 5-Year Outcomes From the SURTAVI Continued Access Study

44. Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk

45. LB-8 | Performance and Use of the Evolut FX Transcatheter Aortic Valve System: Updated Results from the Evolut FX Limited Market Release Clinical Survey

46. 3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

47. Impact of aortic valve replacement in symptomatic low-risk patients with less than severe aortic stenosis

48. COMPUTED TOMOGRAPHY TO ASSESS FEASIBILITY OF CORONARY ACCESS FOLLOWING BALLOON-EXPANDABLE VALVE IMPLANTATION WITHIN A SUPRA-ANNULAR TRANSCATHETER VALVE

49. BIOPROSTHETIC VALVE FRACTURE IN PATIENTS UNDERGOING SELF-EXPANDING TRANSCATHETER AORTIC VALVE REPLACEMENT IN A FAILED SURGICAL VALVE: REAL-WORLD OUTCOMES FROM THE TRANSCATHETER VALVE THERAPY REGISTRY

Catalog

Books, media, physical & digital resources